What is Bio Essence Corporation (BIOE)?

Bio Essence Corporation (BIOE) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of BIOE?

The current price of BIOE is $0.47. Prices are updated in real time on Stocks360.

What is BIOE's price-to-earnings (PE) ratio?

BIOE's trailing twelve-month PE ratio is 12.60, based on current price and earnings per share data available on Stocks360.

What is BIOE's market capitalization?

BIOE's market capitalization is $18,611,326.00, placing it in the small-cap tier.

Bio Essence Corporation (BIOE)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.47

Market Cap

$18.61M

PE (TTM)

12.60

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

6.10

Day Range

$0.47 – $0.47

52-wk Range

$0.05 – $0.52

Avg Volume

N/A

Volume

1.00K

Bio Essence Corporation (BIOE) is a publicly traded company in the Healthcare sector. Latest price: $0.47. Market cap $18.61M. Trailing PE 12.60. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.07 2026-10-30 · $0.47 (+581.16%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bio Essence Corporation

Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements. Founded in 2000, Bio Essence Corporation maintains its corporate headquarters in Irvine, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	12.60×
P/S (TTM)	6.39×
P/B	10.21×
PEG	0.01×
P/FCF (TTM)	17.30×
EV / EBITDA	12.29×
EV / Sales	6.93×
Earnings Yield	6.35%
Free Cash Flow Yield	5.78%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$20.18M
Revenue (TTM)	$2.91M
Net Income (TTM)	$1.18M
Free Cash Flow (TTM)	$1.08M
Net Debt	$1.57M
Working Capital	-$998.52K
Gross Margin	69.68%
Operating Margin	52.86%
Net Margin	52.12%
Return on Equity	-142.50%
Return on Invested Capital	38.84%